Detalles de la búsqueda
1.
Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.
Diabetes Obes Metab
; 24(2): 221-227, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617375
2.
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes.
Diabetes Obes Metab
; 24(2): 212-220, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34595827
3.
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Diabetologia
; 64(11): 2425-2431, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405256
4.
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial.
Diabetologia
; 64(1): 42-55, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33064182
5.
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials.
Diabetes Obes Metab
; 23(12): 2752-2762, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463425
6.
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Diabetes Obes Metab
; 22(4): 492-500, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31696598
7.
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial.
Diabetes Obes Metab
; 22(9): 1639-1647, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32543021
8.
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
Diabetes Obes Metab
; 19(6): 773-782, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27868372
9.
Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.
Diabetes Obes Metab
; 19(5): 734-738, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27935240
10.
Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women.
J Endocr Soc
; 6(9): bvac111, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35935071
11.
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
J Clin Endocrinol Metab
; 106(1): 168-173, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053154
12.
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial.
Lancet Diabetes Endocrinol
; 8(4): 313-324, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135138
13.
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
Expert Opin Pharmacother
; 20(5): 501-510, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730773
14.
Levels of the inflammation marker YKL-40 in young adults exposed to intrauterine hyperglycemia.
Diabetes Res Clin Pract
; 114: 50-4, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27103369
15.
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring".
J Clin Endocrinol Metab
; 106(10): e4307-e4308, 2021 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822975
16.
Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Diabetes Care
; 38(12): 2250-7, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26486191
Resultados
1 -
16
de 16
1
Próxima >
>>